Gapping down
News:
- RPTX -38.8% (announces results of lunresertib and camonsertib combo)
- CADL -31.6% (prices offering consisting of common stock and warrants)
- INO -22.9% (pricing of $30 million public offering)
- TELO -10.4% (White Diamond out with a cautious report on TELO)
- CLSK -3.5% (announces pricing of its offering of $550 mln aggregate principal amount of 0.00% Convertible Senior Notes due 2030)
- WASH -3.3% (prices offering of 1,911,764 shares of its common stock at $34.00 per share)
- EDIT -3.2% (to transition to in vivo gene editing co; to reduce workforce by 65%)
- MG -2% (names new COO)
- ETON -1.6% (entered into a Securities Purchase Agreement)
- BCYC -1.5% (Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification)
- ASND -1.3% (FDA accepts sBLA for TransCon hGH)
- GAIA -1.1% (stock offering)